Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · October 03, 2024

Safety and Efficacy of Continuous Terlipressin Infusion for the Management of Hepatorenal Syndrome–Acute Kidney Injury in a Liver Transplantation Population

Liver Transplantation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Liver Transplantation
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population
Liver Transpl. 2024 Oct 01;30(10)1026-1038, KR Reddy, EM Weinberg, SA Gonzalez, MJ Izzy, DA Simonetto, RT Frederick, RA Rubin, Z Fricker, J Ikahihifo-Bender, M Harte, S Garcia, K Campbell, A Olofson, RF Razavi, JM James, H Patel, G Kim-Lee, S Witkiewicz, W Tobin, K Jamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading